Navigation Links
NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy
Date:10/18/2010

i>.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to statements about NeurogesX' plans to submit a supplemental NDA to the FDA and the timing of such submission; expected data to be included in such submission; additional market reach of expanding the Qutenza label to include treatment of pain associated with HIV-AN and the ability to use the U.S. sales force and other relationships to facilitate commercialization of Qutenza in the potential new indication. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the submission of the supplemental NDA for Qutenza; data submitted may not be sufficient to support FDA approval of Qutenza in the treatment of pain associated with HIV-AN; market acceptance of Qutenza in already approved indications may not be sufficient to support further pursuit of an expanded label for Qutenza, including as a result of physician or patient reluctance to use Qutenza; Qutenza and NeurogesX' other product candidates may have unexpected adverse side effects; and potential alternative therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX, Inc.

Stephen Ghiglieri

Executive Vice President, COO

and CFO

(650) 358-3310




The Ruth Group

Sara Pellegrino (investor
'/>"/>


SOURCE NeurogesX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeurogesX to Present at J.P. Morgan Health Care Conference
2. NeurogesX to Present at Piper Jaffray Health Care Conference
3. NeurogesX Reports Third Quarter 2009 Results
4. NeurogesX to Present at Two November Conferences
5. NeurogesX to Present at UBS Global Life Sciences Conference
6. NeurogesX to Present at Upcoming Fall Conferences
7. NeurogesX Appoints New Board Director and Audit Committee Chairman
8. NeurogesX Reports Second Quarter 2009 Results
9. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
10. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
11. NeurogesX Added to Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... recent study by researchers at the University of ... physical mechanisms governing the interplay of spin and ... limits of ultrafast spintronic devices for data storage ... charge as well as spin-angular momentum. In a ... there is no spin current," explained David Cahill, ...
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as the ... Phase 2 award from the Army Corps of Engineers.  ... that kills all biological contaminants and destroys VOCs and ...
(Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
Breaking Biology Technology:University of Illinois study advances limits for ultrafast nano-devices 2A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... April 2 Bavarian Nordic, the,Danish-based biopharmaceutical company, recently ... the most significant matters in the report,as well as ... revenue for the year 2007 was DKK 332.1 million ... was in line with the Company,s,latest guidance. For 2008, ...
... KONG, April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China,Technology ... or,"CTDC"), a provider of clean and renewable ... business in China, today announced that the,Company ... 5MW Thin Film,Amorphous Silicon Solar Module manufacturing ...
... Fla., April 1, 2008 MiMedx Group, Inc.,(OTC ... (OTC Bulletin,Board: AYXC), today reported that the contemplated ... Florida and related name change, to,MiMedx Group, Inc., ... 2008. As a result of the reverse split ...
Cached Biology Technology:Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 2Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 3Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 4Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 5Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 6Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 7Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 8Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 9CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China 2CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China 3MiMedx Group Announces Post-split Name Change 2MiMedx Group Announces Post-split Name Change 3
(Date:7/10/2014)... centres around a family of enzymes known as heme ... in their active site. At the centre of the ... oxidised (ferryl) when a reacting heme is in an ... remained unanswered for decades is whether this oxidation involves ... (OH). Resolving this fundamental question has implications for understanding ...
(Date:7/10/2014)... Ore. Nuclear engineers at Oregon State University have ... device that should help people all over the world ... intensity, and whether or not it poses a health ... to public demand following the nuclear incident in Fukushima, ... what level of radiation they were being exposed to ...
(Date:7/10/2014)... For children and teens living with a cardiac pacemaker, ... decreased quality of life, reports a study in the ... , the official journal of the Society ... is published by Lippincott Williams & Wilkins , ... "Self-competence may function as a protective factor against lower ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3Sophisticated radiation detector designed for broad public use 2Sophisticated radiation detector designed for broad public use 3For children with pacemakers, 'self-competence' affects quality of life 2
... available in Spanish . A research on ... the world, who recently died at the age of 114, ... contributed to this longevity. The research team, directed by Universitat ... healthy lifestyle, a Mediterranean diet, a temperate climate and regular ...
... have an important role to play in the fate of ... war campaigns, according to a new report in the May ... The researchers found evidence that fungi can lock ... likely to find its way into plants, animals, or the ...
... bubonic plague may be more virulent than their close relatives ... in the May issue of the journal Microbiology. The ... at body temperature. When there is no calcium available, it ... acid, said Professor Brubaker from the University of Chicago, USA. ...
Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
MAb to IgG2 (Fc gamma-2) IgG2 (Fc, gamma-2 epitope)...
... loading buffer is especially formulated for non-denaturing ... acids. The gel loading solution contains a ... add density and facilitate sample loading. EDTA ... require divalent cations and SDS has been ...
Biology Products: